I

Inflammatix, Inc.

98 employees

Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by reading the immune system.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Bioinformatics
Computational Immunology
in-vitro diagnostics
Molecular Diagnostics
Health Diagnostics
Health Care
Big Data
Personalized Medicine

Date founded

2016

Funding rounds raised

Total raised

$102M

from 11 investors over 11 rounds

I

Inflammatix, Inc. raised $1.7M on November 11, 2021

Investors: National Institutes of Health

I

Inflammatix, Inc. raised $102M on March 16, 2021

Investors: Northpond Ventures, D1 Capital Partners L.P. and Khosla Ventures

I

Inflammatix, Inc. raised $1.1M on September 29, 2020

Investors: Darpan Dance Company

I

Inflammatix, Inc. raised $32M on January 10, 2020

Investors: Northpond Ventures, Khosla Ventures and Grey Sky Venture Partners

I

Inflammatix, Inc. raised undisclosed on October 18, 2018

Investors: Northpond Ventures

I

Inflammatix, Inc. raised undisclosed on March 17, 2017

Investors: Khosla Ventures

I

Inflammatix, Inc. raised $1M on January 20, 2017

Investors: Darpan Dance Company

FAQ